Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: tom pavlish who wrote (724)	5/14/1999 12:06:00 PM
From: StockMiser	Read Replies (2) \| Respond to of 2344

Tom - that is the most ill-informed piece of nonsense I've ever read on this message board. BIOM has HUGE amounts of cash - more than enough to complete the Theratope trial - and even beyond that. Several milestone payments are also scheduled, increasing cash even further. If you want to worry about burns, looks at some of the companies in much earlier phase trials with a lot less cash....but certainly NOT Biomira. With the cash on hand, and corporate alliances (BIOM got 500K from Biovector, 1 million from Chiron, btw, and about 30 million more to come), one of Biomira's biggest advantages is that they are in final phase trials and are in absolutely NO need of additional funds. ROFL! There are no "red flags". All biotech investors know how this works. Biotechs in research phase spend money. Go buy AOL or something and leave biotech investing to those that understand the risk/reward. ROFL! SM

To: tom pavlish who wrote (724)	5/14/1999 12:07:00 PM
From: Grislee bear	Respond to of 2344

Usually Companies in development stage are not making money BIOM has the best chance of success, It seems you don't know to much about the company or you are short. Grizzo

To: tom pavlish who wrote (724)	5/14/1999 12:44:00 PM
From: Sultan	Read Replies (2) \| Respond to of 2344

huge loss with HIGH burning rate ? You are not serious. Do your DD indeed. The loss and burn rate is not bad at all. This is the only bio tech I have in my portfolio and the reasons are obvious. When you invest in bio tech, you want a product pipe line that is far along in trial and lots of cash so that the company has staying power. Needless to say, area of specialization in this case is of interest and any break through here will be quite dramatic. BIOM is as good an investment in bio techs that you can make. Investing in Bio techs is always risky. But odds on this one is definitely in your favour.